thymidine has been researched along with End Stage Liver Disease in 3 studies
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
Excerpt | Relevance | Reference |
---|---|---|
"In our study, long-term telbivudine therapy is associated with a sustained improvement of renal function in patients with hepatitis B virus infection after living donor liver transplant." | 7.85 | A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant. ( Chen, YL; Hsieh, CE; Ko, CJ; Lin, CC; Lin, KH; Lin, PY; Ming, YZ, 2017) |
"In our study, long-term telbivudine therapy is associated with a sustained improvement of renal function in patients with hepatitis B virus infection after living donor liver transplant." | 3.85 | A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant. ( Chen, YL; Hsieh, CE; Ko, CJ; Lin, CC; Lin, KH; Lin, PY; Ming, YZ, 2017) |
"352 patients with acute-on-chronic hepatitis B liver failure including 175 cases of low HBV viral load and 177 cases of high HBV viral load were enrolled into this study." | 2.75 | [Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load]. ( Cao, H; Chen, LB; Chen, N; Li, G; Shu, X; Xu, QH; Zhang, K; Zhang, YF, 2010) |
"Lamivudine was switched to telbivudine." | 1.42 | Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy. ( Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Turan, I | 1 |
Yapali, S | 1 |
Bademkiran, F | 1 |
Kose, T | 1 |
Duman, S | 1 |
Sozbilen, M | 1 |
Gunsar, F | 1 |
Ersoz, G | 1 |
Akarca, US | 1 |
Ozutemiz, O | 1 |
Karasu, Z | 1 |
Lin, KH | 1 |
Chen, YL | 1 |
Lin, PY | 1 |
Hsieh, CE | 1 |
Ko, CJ | 1 |
Lin, CC | 1 |
Ming, YZ | 1 |
Chen, LB | 1 |
Cao, H | 1 |
Zhang, YF | 1 |
Shu, X | 1 |
Chen, N | 1 |
Zhang, K | 1 |
Li, G | 1 |
Xu, QH | 1 |
1 trial available for thymidine and End Stage Liver Disease
Article | Year |
---|---|
[Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].
Topics: Adult; Antiviral Agents; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Lam | 2010 |
2 other studies available for thymidine and End Stage Liver Disease
Article | Year |
---|---|
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glome | 2015 |
A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Creatinine; Cross-Sectional Studies; End Stage Liver Dise | 2017 |